文献速递认知障碍与痴呆

APOE 与阿尔茨海默病表型异质性相关:全国队列研究

APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort.
PubMed 文献 · Neurology · 2019-11-08

该研究比较了经AD病理证实的原发性进行性失语(PPA/AD)42例、尸检确诊的遗忘型AD(DAT/AD)1418例及认知正常对照2608例的APOE ε4携带比例。调整性别和年龄后,DAT/AD组携带APOE ε4的比值比显著高于对照组(3.97倍)和PPA/AD组(2.46倍),而PPA/AD组与对照组无显著差异。结论提示APOE ε4是解剖选择性风险因素,优先增加记忆相关内侧颞区对AD病理的易感性。

要点

  • 遗忘型AD患者APOE ε4携带比例显著高于认知正常对照(OR 3.97)。
  • 遗忘型AD患者APOE ε4携带比例显著高于经病理证实的失语型AD(OR 2.46)。
  • 失语型AD与认知正常对照的APOE ε4携带比例无显著差异。

核心结论

  • APOE ε4携带比例在遗忘型AD中升高,但在失语型AD中未升高。
  • APOE ε4可能是解剖选择性风险因素,优先增加记忆相关内侧颞区而非语言相关新皮质对AD病理的易感性。

研究设计与样本

  • 比较三组APOE ε4携带比例:42例经AD病理证实的原发性进行性失语(PPA/AD)来自西北阿尔茨海默病中心临床核心。
  • 1418例尸检确诊的遗忘型AD(DAT/AD)和2608例认知正常对照(NC)来自美国国家阿尔茨海默病协调中心数据库。
  • 采用逻辑回归分析组别与APOE ε4携带状态的关系,根据需要调整发病年龄和性别。

主要发现

  • 以NC为参照并调整性别和年龄,DAT/AD组携带APOE ε4的比值比为3.97。
  • 调整性别和发病年龄后,DAT/AD组携带APOE ε4的比值比为2.46(相比PPA/AD组)。
  • PPA/AD组与NC组之间APOE ε4携带比例无显著差异。
  • PPA亚型包括24例logopenic型、10例语法缺失非流利型、8例混合型(n=5)或严重无法分型(n=3);logopenic与语法缺失亚型的携带者比例相似,均较少携带者。

关键数值与推荐

  • DAT/AD组相比NC组APOE ε4携带比值比3.97(调整性别和年龄)。
  • DAT/AD组相比PPA/AD组APOE ε4携带比值比2.46(调整性别和发病年龄)。

临床怎么用

  • 在AD表型评估中,APOE ε4携带状态更常见于遗忘型而非失语型AD,可辅助理解表型异质性。
  • 对于失语型AD患者,APOE ε4阴性不能排除AD病理。

局限性

  • PPA/AD组样本量较小(42例),亚型分析例数更少。
  • PPA/AD与DAT/AD来源不同队列,可能存在选择偏倚。
  • 研究为横断面比较,不能推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the proportion of APOE ε4 genotype carriers in aphasic vs amnestic variants of Alzheimer disease (AD). METHOD: The proportion of APOE ε4 carriers was compared among the following 3 groups: (1) 42 patients with primary progressive aphasia (PPA) and AD pathology (PPA/AD) enrolled in the Northwestern Alzheimer Disease Center Clinical Core; (2) 1,418 patients with autopsy-confirmed AD and amnestic dementia of the Alzheimer type (DAT/AD); and (3) 2,608 cognitively normal controls (NC). The latter 2 groups were compiled from the National Alzheimer Coordinating Center database. Logistic regression models analyzed the relationship between groups and APOE ε4 carrier status, adjusting for age at onset and sex as needed. RESULTS: Using NC as the reference and adjusting for sex and age, the DAT/AD group was 3.97 times more likely to be APOE ε4 carriers. Adjusting for sex and age at symptom onset, the DAT/AD group was 2.46 times as likely to be carriers compared to PPA/AD. There was no significant difference in the proportion of APOE ε4 carriers for PPA/AD compared to NC. PPA subtypes included 24 logopenic, 10 agrammatic nonfluent, and 8 either mixed (n = 5) or too severe (n = 3) to subtype. The proportion of carriers and noncarriers was similar for logopenic and agrammatic subtypes, both having fewer carriers. CONCLUSION: The proportion of APOE ε4 carriers was elevated in amnestic but not aphasic manifestations of AD. These results suggest that APOE ε4 is an anatomically selective risk factor that preferentially increases the vulnerability to AD pathology of memory-related medial temporal areas rather than language-related neocortices.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Weintraub S, Teylan M, Rader B, et al. APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort. Neurology. 2019. PMID: 31704790. doi:10.1212/WNL.0000000000008666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。